跳至主要内容
临床试验/NCT05761353
NCT05761353已完成不适用

Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema

Cairo University1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2022年6月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
68
试验地点
1
主要终点
Limb volume measurement

研究概览

简要总结

Statement of the problem:

The problem will be stated in a questionary form:

"Which will be more effective endermologie or negative pressure therapy in reducing limb circumference and volume in postmastectomy lymphedema?".

Hypothesis:

It will be hypothesized that:

There is no significant difference between endermologie and negative pressure therapy in reducing circumference and limb volume in post mastectomy lymphedema.

详细描述

Subject:

Sixty- eight women treated for unilateral breast cancer with secondary upper limb lymphedema post mastectomy will participate in this study. Their ages will be ranged from 40 to 60 years, they will be free from any other diseases that will affect or influence the results and the participants will be selected from National Cancer Institute and randomly distributed into two equal groups in number.

Study design:

In this study the patients will be randomly assigned into two groups equal in number (34 patients for each group).

Inclusion Criteria:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Only females will participate in the study.
  • •Patients' age was ranged between 40-60 years.
  • •All patients will suffer from post mastectomy lymphedema.
  • •All patients have a modified radical mastectomy.
  • •All patients suffer from grade II lymphedema without skin changes one year post mastectomy(as defined by the International Society of Lymphology).
  • •All patients are right-dominant hand.
  • •All patients enrolled to the study will have their informed consent.

排除标准

  • •The potential participants will be excluded if they meet one of the following criteria:
  • •primary lymphedema.
  • •Diabetes mellitus.
  • •Pregnancy.
  • •Recurrent cancer.
  • •Current or recent cellulitis.
  • •Current metastases.
  • •Venous thrombosis.
  • •Photosensitivity.
  • •Phlebitis in development stage.
  • •Infection.
  • •Receiving anti-coagulant treatment.

研究组 & 干预措施

Group A (endermologie group)

Experimental

This group includes 34 patients who will receive 30 min Endermologie 3 times per week in addition to their physical therapy program (active range of motion and elevation); hygiene and skin care for 6 weeks.

干预措施: Endermologie (Device)

Group B (Negative pressure therapy group)

Experimental

This group includes34 patients who will receive 30min negative pressure therapy 3 times per week in addition to their physical therapy program (active range of motion and elevation); hygiene and skin care for 6 weeks

干预措施: Negative pressure therapy (Device)

结局指标

主要结局

Limb volume measurement

时间窗: Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb volume and decrease of lymph-edema

Limb volume measurement will be carried out by by measuring the circumference of each segment of the limb between two consecutive circumferences as a truncated zone. The volume of the segment was calculated as: V=h (c1+c1c2+c2 )/12π

Measuring Disability of the arm, shoulder and hand

时间窗: Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb function before and after treatment

Measuring Disability of the arm, shoulder and hand will be carried out by using Quick-DASH questionnaire

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rayda Maher Mohamed Abdelkhalek

assistant lecturer

Cairo University

研究点 (1)

Loading locations...

相似试验